As of 2025-11-05, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 22.51 USD. This relative valuation is based on P/E multiples. With the latest stock price at 73.74 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -69.5%.
The range of the Relative Valuation is (3.21) - 52.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 28.5x - 38.4x | 34.0x |
| Forward P/E multiples | 31.2x - 35.9x | 33.3x |
| Fair Price | (3.21) - 52.65 | 22.51 |
| Upside | -104.4% - -28.6% | -69.5% |
| Date | P/E |
| 2025-11-03 | -652.46 |
| 2025-10-31 | -637.73 |
| 2025-10-30 | -674.37 |
| 2025-10-29 | -680.49 |
| 2025-10-28 | -691.14 |
| 2025-10-27 | -682.04 |
| 2025-10-24 | -702.31 |
| 2025-10-23 | -697.97 |
| 2025-10-22 | -691.23 |
| 2025-10-21 | -700.10 |
| 2025-10-20 | -678.10 |
| 2025-10-17 | -648.25 |
| 2025-10-16 | -657.78 |
| 2025-10-15 | -627.53 |
| 2025-10-14 | -634.10 |
| 2025-10-13 | -606.02 |
| 2025-10-10 | -600.83 |
| 2025-10-09 | -635.69 |
| 2025-10-08 | -627.62 |
| 2025-10-07 | -605.00 |
| 2025-10-06 | -638.27 |
| 2025-10-03 | -649.98 |
| 2025-10-02 | -631.97 |
| 2025-10-01 | -625.14 |
| 2025-09-30 | -594.44 |
| 2025-09-29 | -568.36 |
| 2025-09-26 | -572.27 |
| 2025-09-25 | -568.98 |
| 2025-09-24 | -589.12 |
| 2025-09-23 | -622.21 |
| 2025-09-22 | -656.54 |
| 2025-09-19 | -648.82 |
| 2025-09-18 | -613.60 |
| 2025-09-17 | -577.94 |
| 2025-09-16 | -576.26 |
| 2025-09-15 | -588.06 |
| 2025-09-12 | -546.98 |
| 2025-09-11 | -559.67 |
| 2025-09-10 | -528.04 |
| 2025-09-09 | -546.36 |
| 2025-09-08 | -565.61 |
| 2025-09-05 | -574.40 |
| 2025-09-04 | -570.67 |
| 2025-09-03 | -544.59 |
| 2025-09-02 | -569.60 |
| 2025-08-29 | -601.01 |
| 2025-08-28 | -597.90 |
| 2025-08-27 | -610.19 |
| 2025-08-26 | -615.02 |
| 2025-08-25 | -639.24 |